Is Can-Fite BioPharma Ltd. (CANF) a Buy, Sell, or Hold?
AMEX : CANF
Can-Fite BioPharma Ltd.
$3.225 USD
-$0.06 (-1.68%)
- Volume
- 83.56K
- Average Volume
- 1.91M
- Market Capitalization
- $1.74M
- P/E Ratio
- -0.73
- Dividend Yield
- 0.00%
- Price Target
- $8.00
- Year High
- $21.00
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.46
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
0
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
-$
CANF Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CANF Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Farbstein Motti | officer: CEO, CFO and COO | 2026-06-04 | A-Award | 2.043 | 2026-06-08 |
| Fishman Pnina | director, officer: Chief Scientific Officer | 2026-06-04 | A-Award | 2.043 | 2026-06-08 |
| Tamir Ilan | director | 2026-04-25 | 2.25 | 2026-04-23 | |
| Regev Guy | director | 2026-03-18 | 0 | 2026-04-06 | |
| Regev Guy | director | 2017-02-08 | 2826.14 | 2026-04-06 | |
| Regev Guy | director | 2020-06-15 | 241.47 | 2026-04-06 | |
| Regev Guy | director | 2023-08-01 | 25.21 | 2026-04-06 | |
| Regev Guy | director | 2024-08-07 | 26.56 | 2026-04-06 | |
| Regev Guy | director | 2026-04-25 | 2.18 | 2026-04-06 | |
| Bornstein Yoseph | director | 2021-06-22 | 241.47 | 2026-03-18 | |
| Bornstein Yoseph | director | 2023-08-01 | 25.21 | 2026-03-18 | |
| Bornstein Yoseph | director | 2024-08-07 | 26.56 | 2026-03-18 | |
| Bornstein Yoseph | director | 2026-04-25 | 2.18 | 2026-03-18 |